Detailed Quote
5i Report
Review of Cipher Pharmaceuticals
AUG 16, 2018 - Dermatology pharmaceutical business with recent acquisition and growth in product pipeline, with some mixed results in the past. Coverage dropped until some visibility emerges.
Download ReportCompany Profile
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
Q: Please comment on CPH latest earnings. It looks like a bit of a mixed bag. The stock is expensive, but they are throwing off a lot of FCF and their strategy looks solid going forward. Thank you.
Q: A bit of an earnings miss, but the future is looking promising. Your opinion going forward please.
Q: any comment on earnings should i switch to Well health or Vitalhub
Insiders
Share Information
News and Media